Gelita's Bioactive Collagen Peptide product, Fortigel, has been authorized by The National Health Agency (Anvisa) for its joint health benefits. It has received a functional claim approval in Brazil. It has been authorized with the wording “may contribute to the maintenance of joint health” on the labels of food supplements formulated with the ingredient. The decision was published on September 26 in DOU (Diário Oficial da União), for the dosage of 5g a day. These collagen peptides from Gelita are the only collagen to have such endorsement in the Brazilian market and has other approved claims in Canada and Japan, according to the release.
Barentz International shared the news of its acquisition of Viachem, Ltd. This will expand the brand's market research function and digitally enabled sales and marketing capabilities. Viachem represents a market growth engine for Barentz and its suppliers. The team will continue to be led by Mike Efting, Viachem’s President & Founder, and offices will remain in Plano, TX and Augusta, GA. The brand touts that the acquisition expands capabilities in the areas of development, research, market opportunities, digital marketing capabilities, sales, and more.
NOTE: WholeFoods Magazine is a business-to-business publication. Information on this site should not be considered medical advice or a way to diagnose or treat any disease or illness. Always seek the advice of a medical professional before making lifestyle changes, including taking a dietary supplement. The opinions expressed by contributors and experts quoted in articles are not necessarily those of the publisher or editors of WholeFoods.